(Total Views: 304)
Posted On: 04/16/2019 4:06:00 PM
Post# of 72443
Your point of only one suitor if someone is indeed helping us thru the EMA is so obvious I missed it. Thanks for a slap of reality.
I also missed in the PR that an oral form of K will actually " enhance the therapeutic benefits based on its pharmacokinetics, and broaden its market potential by meeting cancer patient’s strong preference for oral meds."
Just keeps getting better and better.
I also missed in the PR that an oral form of K will actually " enhance the therapeutic benefits based on its pharmacokinetics, and broaden its market potential by meeting cancer patient’s strong preference for oral meds."
Just keeps getting better and better.
(2)
(0)Scroll down for more posts ▼
